A report on brachytherapy for prostate cancer, 2004;La curiethérapie du cancer prostatique: Un état des lieux en 2004

Oncologie

Volumn 6, Issue 6, 2004, Pages 422-427

  Cosset, J M ^a   Flam, T ^b   Thiounn, N ^c   Rosenwald, J C ^a   Chauveinc, L ^a  

^a INSTITUT CURIE   (France)

^b Institut Cochin   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Brachytherapy; Prostate cancer

Indexed keywords

IODINE 125; PALLADIUM 103;

ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; DOSIMETRY; HUMAN; INCONTINENCE; POSTOPERATIVE COMPLICATION; PROSTATE CANCER; PROSTATECTOMY; RADIATION DOSE; RADIATION INJURY; RADIATION PROTECTION; RECTUM DISEASE; RISK ASSESSMENT; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 12844252559     PISSN: 12923818     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10269-004-0105-9     Document Type: Article

References (20)

1. Aronowitz JN (2002) Dawn of prostate brachytherapy: 1915-1930. Int J Radiat Oncol Biol Phys 54: 712-8
2. Buron C, Chauveinc L, Salem N, et al. (2004) An economic evaluation of interstitial brachytherapy, radical prostatectomy and external beam radiotherapy for localized prostate cancer: results during the first year after therapy. Radiother Oncol 71 [Suppl. 2]: S86
3. Chauveinc L, Salem N, Pommier P, et al. (2002) La curiethérapie prostatique par implantation permanente d'iode-125: les règles de bonne conduite. Cancer/Radiothérapie 6: 112-5
4. . Chauveinc L, Osseili A, Flam T, et al. Migration des grains d'iode 125 après curiethérapie prostatique: étude d'une série de 170 patients. Cancer/Radiothérapie, in press
5. Flam TA, Peyromaure M, Chauveinc L, et al. (2004) Post-brachytherapy transurethral resection of the prostate in patients with localized prostate cancer. J Urol 172: 108-11
6. Grimm PD, Blasko JC, Sylvester JE, et al. (2001) 10-year biochemical (prostatespecific antigen) control of prostate cancer with (125) I brachytherapy. Int J Radiat Oncol Biol Phys 51: 31-40
7. Holm HH, Juul N, Pederson JF (1983) Transperineal I-125 seed implantation in prostatic cancer guided by transrectal ultrasonography. J Urol 130: 283-6
8. Kollmeier MA, Stock RG, Stone N (2003) Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up: importance of patient selection and implant quality. Int J Radiat Oncol Biol Phys 57: 645-53
9. Kupelian PA, Potters L, Khuntia D, et al. (2004) Radical prostatectomy, external beam radiotherapy ≥ 72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer. Int J Radiat Oncol Biol Phys 58: 25-33
10. Merrick GS, Butler WM, Lief JH, Dorsey AT (2000) Temporal resolution of urinary morbidity following prostate brachytherapy. Int J Radiat Oncol Biol Phys 47: 121-8
11. Merrick GS, Butler WM, Wallner KE, et al. (2003) Long-term urinary quality of life after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 56: 454-61
12. Merrick GS, Butler WM (2004) Rectal function following permanent prostate brachytherapy. W V Med J 100: 18-20
13. Merrick GS, Wallner KE, Butler WM (2004) Patient selection for prostate brachytherapy: more myth than fact. Oncology (Huntingt) 18: 445-52
14. Pasteau O, Degrais P (1913) De l'emploi du radium dans les cancers de la prostate. J Urol (Paris): 341-5
15. Potters L, Klein EA, Kattan MW, et al. (2004) Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation. Radiother Oncol 71: 29-33
16. Ragde H, Korb LJ, Elgamal AA, et al. (2000) Modern prostate brachytherapy. Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up. Cancer 89: 135-41
17. Stone NN, Stock RG (2002) Permanent seed implantation for localized adenocarcinoma of the prostate. Curr Urol Rep 3: 201-6
18. Woolsey J, Miller N, Theodorescu D (2003) Permanent interstitial brachytherapy for prostate cancer: a current review. World J Urol 21: 209-19
19. Zelefsky MJ, Hollister T, Raben A, et al. (2000) Five-year biochemical outcome and toxicity with transperineal CT-planned permanent 1-125 prostate implantation for patients with localized prostate cancer. Int J Radiat Oncol Biol Phys 47: 1261-6
20. Zelefsky MJ, Yamada Y, Marion C, et al. (2003) Improved conformality and decreased toxicity with intraoperative computer-optimized transperineal ultrasound-guided prostate brachytherapy. Int J Radiat Oncol Biol Phys 55: 956-63